Article ID Journal Published Year Pages File Type
8447406 European Journal of Cancer 2011 11 Pages PDF
Abstract
This family of genes are dysregulated in NSCLC and are subject to epigenetic regulation. Whilst the anti-angiogenic properties of IL-20 require further clarification, targeting this family via epigenetic means may be a viable therapeutic option in lung cancer treatment.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF
Authors
, , ,